Pura Vida Investments’s Tandem Diabetes Care TNDM Stock Holding History

Pura Vida Investments’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,500	Closed	-$1.72M	–	62
2024 Q2	$1.63M	Sell	40,500 -2,000	-5%	-$83.4K	1.03%	30
2024 Q1	$1.5M	Buy	+42,500	New	+$1.14M	0.25%	39
2022 Q4	–	Sell	-75,000	Closed	-$3.59M	–	247
2022 Q3	$3.59M	Buy	+75,000	New	+$4.11M	0.21%	107
2019 Q4	–	Sell	-40,000	Closed	-$2.36M	–	121
2019 Q3	$2.36M	Buy	40,000 +30,000	+300%	+$1.91M	0.4%	61
2019 Q2	$645K	Sell	10,000 -30,000	-75%	-$1.94M	0.1%	93
2019 Q1	$2.54M	Sell	40,000 -56,914	-59%	-$2.99M	0.36%	70
2018 Q4	$3.68M	Buy	96,914 +20,981	+28%	+$741K	0.73%	29
2018 Q3	$3.25M	Buy	+75,933	New	+$2.65M	0.68%	48
2016 Q1	–	Sell	-8,287	Closed	-$979K	–	98
2015 Q4	$979K	Buy	+8,287	New	+$822K	0.41%	60
2015 Q2	–	Sell	-18,774	Closed	-$2.37M	–	83
2015 Q1	$2.37M	Buy	+18,774	New	+$2.44M	1.22%	34

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's TNDM Position: Q3 2024 in Review

Pura Vida Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 40,500 shares — an estimated $1.72M sold.

Pura Vida Investments first reported a position in TNDM in Q1 2015 and held it in 10 quarters. The position peaked at $3.68M in Q4 2018. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

Pura Vida Investments reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
Pura Vida Investments sold 40,500 Tandem Diabetes Care shares in Q3 2024, an estimated $1.72M.
Pura Vida Investments first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 10 quarters.
Pura Vida Investments's Tandem Diabetes Care position peaked at $3.68M in Q4 2018.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.